Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
25 /100
LOW RISK
Score updated Aug 28, 2026

OCUL — Ocular Therapeutix, Inc. Dilution Risk Tracker

Track OCUL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OCUL — Get alerts when the score changes →

As of August 28, 2026, Ocular Therapeutix, Inc. (OCUL) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Ocular Therapeutix, Inc. has a market capitalization of $1.97B, 219.62M shares outstanding, 272 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for OCUL.
🔔 Track OCUL — Get forecast alerts →

Market Data

Market Cap$1.97B
Shares Outstanding219.62M
Float184.63M
Cash$598.64M
Debt$18.00M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.6% shares (2026Q1 vs prior)
272 institutional holders · 244.92M shares
#1 FMR LLC 32.65M shares
#2 Avoro Capital Advisors LLC 23.09M shares
#3 Deep Track Capital, LP 19.69M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest26.74M
Days to Cover13.5
% of Float14.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual OCUL Dilution Snapshot

Ocular Therapeutix, Inc. (OCUL) has a DilutionScore of 25/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track OCUL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OCUL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OCUL
OCUL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.